News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.

New drug combination boosts survival in advanced stomach and esophageal cancers

Patients whose metastatic stomach or esophageal cancers were driven by a mutatedHER2 gene had markedly improved response rates and survival when bevacizumab (Avastin) was added to a standard drug combination.